Intracoronary adenosine admin- istered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of no reflow phenomenon. Catheter Cardiovasc Interv. 2000;51:27 31. 676. Barcin C, Denktas AE, Lennon RJ, et al. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv. 2004;61:484 91. 677. Fischell TA, Haller S, Pulukurthy S, et al. Nicardipine and adenosine flush cocktail to prevent no-reflow during rotational atherectomy. Cardiovasc Revasc Med. 2008;9:224 8. 678. Hillegass WB, Dean NA, Liao L, et al. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following per- cutaneous coronary interventions: initial human clinical experience. J Am Coll Cardiol. 2001;37:1335 43. 679. Huang RI, Patel P, Walinsky P, et al. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;68:671 6. 680. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999;33:654 60. 681. Kaplan BM, Benzuly KH, Kinn JW, et al. Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intra- coronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn. 1996; 39:113 8. 682. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intra- coronary adenosine as an adjunct to primary angioplasty in acute myo- cardial infarction. Circulation. 2000;101:2154 9. 683. Ono H, Osanai T, Ishizaka H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004;148:611. 684. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation. 1994; 89:2514 8. 685. 